Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 26 (RPL5P26)

Target
RPL5P26
Molecular classification
Other
01

Overview

Ribosomal protein L5 pseudogene 26 (RPL5P26) is a processed pseudogene—a non-functional genomic sequence resembling the ribosomal protein L5 (RPL5) gene. Unlike its parent gene, RPL5P26 does not encode a functional protein and typically has no biological activity. There are many processed pseudogenes of ribosomal proteins scattered throughout the genome; they are typically regarded as genomic fossils with no direct involvement in cellular function or disease. RPL5P26 is not a therapeutic target, receptor, enzyme, or transporter[5]. Context and clarification: - Pseudogenes like RPL5P26 are genomically similar to protein-coding genes but usually lack protein-coding potential due to disabling mutations or the absence of regulatory elements required for expression[5]. - The functional gene RPL5 (Ribosomal protein L5) is essential for ribosome assembly and has disease relevance, but pseudogenes such as RPL5P26 do not share these properties[1][4]. - Based on gene databases, RPL5P26 lacks evidence for functional protein expression, disease involvement, or druggability, thus should not be listed as a therapeutic target[5].

Other names
RPL5_13_1059RPL5P26

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 26 (RPL5P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 26 (RPL5P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call